BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15199750)

  • 21. A monoclonal expansion of Epstein-Barr virus-infected natural killer cells after allogeneic peripheral blood stem cell transplantation.
    Isobe Y; Hamano Y; Ito Y; Kimura H; Tsukada N; Sugimoto K; Komatsu N
    J Clin Virol; 2013 Feb; 56(2):150-2. PubMed ID: 23194777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
    Taketani T; Kikuchi A; Inatomi J; Hanada R; Kawaguchi H; Ida K; Oh-Ishi T; Arai T; Kishimoto H; Yamamoto K
    Bone Marrow Transplant; 2002 Mar; 29(6):531-3. PubMed ID: 11960276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting.
    Yoshiba F; Hagihara M; Tazume K; Ogawa Y; Kishi K; Higuchi A; Kato S; Hotta T
    Bone Marrow Transplant; 2003 Jul; 32(1):107-10. PubMed ID: 12815486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.
    Lucas KG; Salzman D; Garcia A; Sun Q
    Cancer; 2004 May; 100(9):1892-901. PubMed ID: 15112270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two young adult cases of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis with monoclonal proliferation of virus-infected cells within a short period after primary infection].
    Idutsu K; Abe Y; Matsushima T; Sada E; Ohtsuka R; Kiyasu J; Shiratsuchi M; Kotoh K; Nishimura J; Ohga S; Takayanagi R
    Rinsho Ketsueki; 2008 Nov; 49(11):1541-7. PubMed ID: 19047785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Remission induction of refractory diffuse large B-cell lymphoma with allogeneic peripheral blood stem cell transplantation followed by interferon-alpha and donor lymphocyte infusion].
    Kawano I; Tsukada J; Toda Y; Ogawa R; Higashi T; Iwashige A; Ota T; Kubota A; Mizobe T; Morimoto H; Machida S; Tanaka Y
    Rinsho Ketsueki; 2004 Feb; 45(2):155-60. PubMed ID: 15045825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study of Epstein-Barr virus-associated hemophagocytic syndrome successfully treated with VP16 and analysis of T cell receptor chain genes of the bone marrow cells].
    Noma T; Kou K; Yoshizawa I; Kawano Y; Itoh M; Maeda K; Miyashita T; Mizutani S
    Rinsho Ketsueki; 1992 Dec; 33(12):1809-17. PubMed ID: 1336076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-associated enteritis with multiple ulcers after stem cell transplantation: first histologically confirmed case.
    Tashiro Y; Goto M; Takemoto Y; Sato E; Shirahama H; Utsunomiya A; Eizuru Y; Yonezawa S
    Pathol Int; 2006 Sep; 56(9):530-7. PubMed ID: 16930333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantation].
    Matsui S; Takeda Y; Isshiki Y; Yamazaki A; Nakao S; Takaishi K; Nagao Y; Hasegawa N; Togasaki E; Shimizu R; Kawajiri C; Sakai S; Mimura N; Takeuchi M; Ohwada C; Sakaida E; Iseki T; Imadome K; Nakaseko C
    Rinsho Ketsueki; 2016 May; 57(5):624-9. PubMed ID: 27263789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polyclonal activation due to Epstein-Barr virus superinfection in a case with chronic hepatitis B].
    Bakir Ozbey S; Mistik R; Gürcüoğlu E; Oral B; Göral G
    Mikrobiyol Bul; 2007 Oct; 41(4):607-12. PubMed ID: 18173082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Mlynarczewska A; Jaskula E; Lange A
    Br J Haematol; 2006 Feb; 132(3):326-32. PubMed ID: 16409297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.
    Ishimura M; Ohga S; Nomura A; Toubo T; Morihana E; Saito Y; Nishio H; Ide M; Takada H; Hara T
    Am J Hematol; 2005 Nov; 80(3):207-12. PubMed ID: 16247742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
    Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
    J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?
    Meijer E; Spijkers S; Moschatsis S; Boland GJ; Thijsen SF; van Loon AM; Verdonck LF
    Transpl Infect Dis; 2005 Mar; 7(1):4-10. PubMed ID: 15984942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant.
    Zamkoff KW; Bergman S; Beaty MW; Buss DH; Pettenati MJ; Hurd DD
    Bone Marrow Transplant; 2003 Feb; 31(3):219-22. PubMed ID: 12621485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
    Matsue K; Aoki T; Odawara J; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuch M
    Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab therapy for Epstein-Barr virus-related chronic hepatitis following living donor kidney transplantation.
    Ohta K; Shimizu M; Nakai A; Toma T; Kasahara Y; Arii C; Yachie A; Kawamura T; Aikawa A; Hasegawa A; Sato K; Yokoyama H; Ishikawa I; Koizumi S
    Am J Kidney Dis; 2006 Dec; 48(6):986-9. PubMed ID: 17162154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of hemophagocytic lymphohistiocytosis with prolonged remission after syngeneic bone marrow transplantation.
    Hasegawa D; Sano K; Kosaka Y; Hayakawa A; Nakamura H
    Bone Marrow Transplant; 1999 Aug; 24(4):425-7. PubMed ID: 10467334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.